Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | VANGUARD GROUP INC | 5,789,960 10.710% | 276,811 (+5.02%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | BlackRock Inc. BLK | 9,604,073 17.800% | 1,153,051 (+13.64%) | Filing History |
| 2022-02-14 7:03 pm Purchase | 2021-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | ARMISTICE CAPITAL LLC | 4,136,000 7.800% | 1,016,000 (+32.56%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | VANGUARD GROUP INC | 5,513,149 10.370% | 215,071 (+4.06%) | Filing History |
| 2022-01-27 5:14 pm Unchanged | 2021-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | BlackRock Inc. BLK | 8,451,022 15.900% | 0 (Unchanged) | Filing History |
| 2022-01-26 09:16 am Sale | 2021-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | BlackRock Inc. BLK | 8,451,022 15.900% | -461,779 (-5.18%) | Filing History |